Risk variables associated with the outcome of kidney recipients >70 years of age in the new millennium

Nephrology Dialysis Transplantation

Volumn 26, Issue 8, 2011, Pages 2706-2711

  Heldal, Kristian ^a,b,c   Hartmann, Anders ^b,c   Leivestad, Torbjørn ^d   Foss, Aksel ^b   Midtvedt, Karsten ^b  

^a Section of Cardiology Nephrology and Endocrinology   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

elderly patients; kidney transplantation; patient survival; risk factors

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID;

AGE; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG DOSE REDUCTION; ELDERLY CARE; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HAZARD RATIO; HUMAN; IMPAIRED GLUCOSE TOLERANCE; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE;

AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79961098370     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq786     Document Type: Article

References (22)

1. Rao PS, Merion RM, Ashby VB et al. Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients. Transplantation 2007;83:1069-1074 (Pubitemid 46659119)
2. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999;341:1725-1730
3. Oniscu GC, Brown H, Forsythe JL. How old is old for transplantation? Am J Transplant 2004;4:2067-2074 (Pubitemid 39611636)
4. Oniscu GC, Brown H, Forsythe JL. How great is the survival advantage of transplantation over dialysis in elderly patients? Nephrol Dial Transplant 2004;19:945-951 (Pubitemid 38455669)
5. Sener A, Schweitzer EJ, Munivenkatappa R et al. Deceased-donor renal transplantation in the geriatric population demonstrates equal graft survival compared with younger recipients. Transplantation 2009;87:1549-1554
6. Heldal K, Hartmann A, Grootendorst DC et al. Benefit of kidney transplantation beyond 70 years of age. Nephrol Dial Transplant 2010;25:1680-1687
7. Petersen E, Baird BC, Shihab F et al. The impact of recipient history of cardiovascular disease on kidney transplant outcome. ASAIO J 2007;53:601-608 (Pubitemid 47469597)
8. Aalten J, Hoogeveen EK, Roodnat JI et al. Associations between prekidney-transplant risk factors and post-transplant cardiovascular events and death. Transpl Int 2008;21:985-991
9. Hjelmesæth J, Hartmann A, Leivestad T et al. The impact of earlydiagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 2008;69:588-595 (Pubitemid 43164454)
10. Heldal K, Hartmann A, Leivestad T et al. Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity. Transplantation 2009;87:1045-1051
11. Jassal SV, Schaubel DE, Fenton SS. Baseline comorbidity in kidney transplant recipients: a comparison of comorbidity indices. Am J Kidney Dis 2005;46:136-142 (Pubitemid 40848442)
12. Bergrem HA, Valderhaug TG, Hartmann A, Bergrem H, Hjelmesaeth J, Jenssen T. Glucose tolerance before and after renal transplantation. Nephrol Dial Transplant 2010;25:985-992
13. de Fijter JW, Mallat MJ, Doxiadis II et al. Increased immunogenicity and cause of graft loss of old donor kidneys. J Am Soc Nephrol 2001;12:1538-1546 (Pubitemid 32666338)
14. Meier-Kriesche HU, Morris JA, Chu AH et al. Mycophenolate mofetil vs azathioprine in a large population of elderly renal transplant patients. Nephrol Dial Transplant 2004;19:2864-2869 (Pubitemid 39480985)
15. Badowski M, Gurk-Turner C, Cangro C et al. The impact of reduced immunosuppression on graft outcomes in elderly renal transplant recipients. Clin Transplant 2009
16. Johnson DW, Nicol DL, Purdie DM et al. Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients? Transplantation 2002;73:1158-1163 (Pubitemid 34415454)
17. Ekberg H, Tedesco-Silva H, Demirbas A et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007;357:2562-2575 (Pubitemid 350294223)
18. Fellstrom B, Jardine AG, Soveri I et al. Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation. Am J Transplant 2005;5:1986-1991 (Pubitemid 41039875)
19. Jardine AG, Fellstrom B, Logan JO et al. Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study. Am J Kidney Dis 2005;46:529-536 (Pubitemid 41208190)
20. Jager KJ, Stel VS, Wanner C et al. The valuable contribution of observational studies to nephrology. Kidney Int 2007;72:671-675 (Pubitemid 47373787)
21. Stel VS, Jager KJ, Zoccali C et al. The randomized clinical trial: an unbeatable standard in clinical research? Kidney Int 2007;72:539-542 (Pubitemid 47312791)
22. Jager KJ, van Dijk PC, Dekker FW et al. The epidemic of aging in renal replacement therapy: an update on elderly patients and their outcomes. Clin Nephrol 2003;60:352-360 (Pubitemid 37407693)